Elena Élez

机构：Hebron University, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology · ORCID：0000-0002-4653-6324

发表论文 585 篇 · 总被引 20313 次 · h-index 59

代表论文

• Intratumoral Fusobacterium species and survival in resectable colorectal cancer: a multicenter cohort study (2026 · ESMO Open)
• Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy (2026 · Journal for ImmunoTherapy of Cancer)
• Rechallenge With Anti-Human Epidermal Growth Factor Receptor 2 Therapy Guided by Liquid Biopsy in HER2 -Amplified Metastatic Colorectal Cancer (2026 · JCO Precision Oncology)
• Table 4 from BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026)
• Table 5 from BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026)
• Table 2 from BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026)